Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study.

Brixner D, Ermakova A, Xiong Y, Sieradzan R, Sacks N, Cyr P, Taylor SD.

Clin Ther. 2019 Feb;41(2):303-313.e1. doi: 10.1016/j.clinthera.2018.12.014. Epub 2019 Jan 30.

PMID:
30709610
2.
3.

Real-world comparison of the effectiveness and safety of different bowel preparation agents.

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir SP.

Clin Exp Gastroenterol. 2018 Aug 16;11:289-299. doi: 10.2147/CEG.S171861. eCollection 2018.

4.

Burden of Acute Myeloid Leukemia Among Older, Newly Diagnosed Patients: Retrospective Analysis of Data From the 2010-2012 Medicare Limited Data Set.

Sacks NC, Cyr PL, Louie AC, Liu Y, Chiarella MT, Sharma A, Chung KC.

Clin Ther. 2018 May;40(5):692-703.e2. doi: 10.1016/j.clinthera.2018.03.012. Epub 2018 Apr 17.

5.

Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy.

Young LE, Sacks NC, Cyr PL, Sharma A, Dahdal DN.

SAGE Open Med. 2017 Aug 31;5:2050312117727999. doi: 10.1177/2050312117727999. eCollection 2017.

6.

Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D.

Sacks NC, Burgess JF Jr, Cabral HJ, Pizer SD.

Health Econ. 2017 Jun;26(6):753-764. doi: 10.1002/hec.3355. Epub 2016 May 6.

PMID:
27150938
7.

Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture?

Sacks NC, Ash AS, Ghosh K, Rosen AK, Wong JB, Rosen AB.

Am Heart J. 2015 Dec;170(6):1211-9. doi: 10.1016/j.ahj.2015.09.009. Epub 2015 Sep 21.

8.

The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?

Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD.

J Manag Care Spec Pharm. 2015 Aug;21(8):678-87.

9.

Recent national trends in acute myocardial infarction hospitalizations in Medicare: shrinking declines and growing disparities.

Sacks NC, Ash AS, Ghosh K, Rosen AK, Wong JB, Cutler DM, Rosen AB.

Epidemiology. 2015 Jul;26(4):e46-7. doi: 10.1097/EDE.0000000000000298. No abstract available.

PMID:
25924109
10.

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab.

Santegoets SJ, Stam AG, Lougheed SM, Gall H, Jooss K, Sacks N, Hege K, Lowy I, Scheper RJ, Gerritsen WR, van den Eertwegh AJ, de Gruijl TD.

J Immunother Cancer. 2014 Sep 16;2:31. doi: 10.1186/s40425-014-0031-3. eCollection 2014.

11.

Proactive enteral tube feeding in pediatric patients undergoing chemotherapy.

Sacks N, Hwang WT, Lange BJ, Tan KS, Sandler ES, Rogers PC, Womer RB, Pietsch JB, Rheingold SR.

Pediatr Blood Cancer. 2014 Feb;61(2):281-5. doi: 10.1002/pbc.24759. Epub 2013 Sep 9.

PMID:
24019241
12.

Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.

Sacks NC, Burgess JF Jr, Cabral HJ, Pizer SD, McDonnell ME.

J Gen Intern Med. 2013 Jul;28(7):876-85. doi: 10.1007/s11606-013-2342-3. Epub 2013 Feb 13.

13.

T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.

Santegoets SJ, Stam AG, Lougheed SM, Gall H, Scholten PE, Reijm M, Jooss K, Sacks N, Hege K, Lowy I, Cuillerot JM, von Blomberg BM, Scheper RJ, van den Eertwegh AJ, Gerritsen WR, de Gruijl TD.

Cancer Immunol Immunother. 2013 Feb;62(2):245-56. doi: 10.1007/s00262-012-1330-5. Epub 2012 Aug 10.

PMID:
22878899
14.

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.

van den Eertwegh AJ, Versluis J, van den Berg HP, Santegoets SJ, van Moorselaar RJ, van der Sluis TM, Gall HE, Harding TC, Jooss K, Lowy I, Pinedo HM, Scheper RJ, Stam AG, von Blomberg BM, de Gruijl TD, Hege K, Sacks N, Gerritsen WR.

Lancet Oncol. 2012 May;13(5):509-17. doi: 10.1016/S1470-2045(12)70007-4. Epub 2012 Feb 10.

PMID:
22326922
15.

A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysis.

Sacks N, Cabral H, Kazis LE, Jarrett KM, Vetter D, Richmond R, Moore TJ.

J Med Internet Res. 2009 Oct 23;11(4):e43. doi: 10.2196/jmir.1263.

16.

Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.

Withycombe JS, Post-White JE, Meza JL, Hawks RG, Smith LM, Sacks N, Seibel NL.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1249-54. doi: 10.1002/pbc.22237.

17.

Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.

Higano CS, Corman JM, Smith DC, Centeno AS, Steidle CP, Gittleman M, Simons JW, Sacks N, Aimi J, Small EJ.

Cancer. 2008 Sep 1;113(5):975-84. doi: 10.1002/cncr.23669.

18.

Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.

Hobbie WL, Moshang T, Carlson CA, Goldmuntz E, Sacks N, Goldfarb SB, Grupp SA, Ginsberg JP.

Pediatr Blood Cancer. 2008 Nov;51(5):679-83. doi: 10.1002/pbc.21683.

19.

Single-change items did not measure change in quality of life.

Rose AJ, Sacks NC, Deshpande AP, Griffin SY, Cabral HJ, Kazis LE.

J Clin Epidemiol. 2008 Jun;61(6):603-8. doi: 10.1016/j.jclinepi.2007.07.010. Epub 2008 Jan 14.

PMID:
18471664
20.

Hormone replacement therapy in women with previous breast cancer.

Marsden J, Baum M, Sacks NP.

Trends Endocrinol Metab. 1998 Jan-Feb;9(1):32-8.

PMID:
18406232
21.

Children's Oncology Group (COG) Nutrition Committee.

Rogers PC, Melnick SJ, Ladas EJ, Halton J, Baillargeon J, Sacks N; Children's Oncology Group (COG) Nutrition Committee.

Pediatr Blood Cancer. 2008 Feb;50(2 Suppl):447-50; discussion 451. Review.

PMID:
18064639
22.

Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.

Small EJ, Sacks N, Nemunaitis J, Urba WJ, Dula E, Centeno AS, Nelson WG, Ando D, Howard C, Borellini F, Nguyen M, Hege K, Simons JW.

Clin Cancer Res. 2007 Jul 1;13(13):3883-91.

23.

A clinical development paradigm for cancer vaccines and related biologics.

Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G; Cancer Vaccine Clinical Trial Working Group.

J Immunother. 2007 Jan;30(1):1-15. Review.

PMID:
17198079
24.
25.

A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from children's oncology group.

Ladas EJ, Sacks N, Meacham L, Henry D, Enriquez L, Lowry G, Hawkes R, Dadd G, Rogers P.

Nutr Clin Pract. 2005 Aug;20(4):377-93. Review.

PMID:
16207678
27.

Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia.

Baillargeon J, Langevin AM, Lewis M, Grady JJ, Thomas PJ, Mullins J, Estrada J, Pitney A, Sacks N, Pollock BH.

Cancer. 2005 Apr 15;103(8):1725-9.

28.

Mortality in overweight and underweight children with acute myeloid leukemia.

Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, Alonzo TA.

JAMA. 2005 Jan 12;293(2):203-11.

PMID:
15644547
29.

Erosive adenomatosis of the nipple--a report of three cases.

Davies GL, Sacks NP, Gordon AB, Trott PA.

Ann R Coll Surg Engl. 2004 Mar;86(2):146-7. No abstract available.

30.

Is mastectomy overtreatment for Paget's disease of the nipple?

Singh A, Sutton RJ, Baker CB, Sacks NP.

Breast. 1999 Aug;8(4):191-4. Erratum in: Breast. 1999 Dec;8(6):350.

31.

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

Ring A, Webb A, Ashley S, Allum WH, Ebbs S, Gui G, Sacks NP, Walsh G, Smith IE.

J Clin Oncol. 2003 Dec 15;21(24):4540-5.

PMID:
14673041
32.

Catheter fracture: a rare complication of totally implantable venous devices.

Maisey NR, Sacks N, Johnston SR.

Breast. 2003 Aug;12(4):287-9.

33.

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer.

Archer CD, Parton M, Smith IE, Ellis PA, Salter J, Ashley S, Gui G, Sacks N, Ebbs SR, Allum W, Nasiri N, Dowsett M.

Br J Cancer. 2003 Sep 15;89(6):1035-41.

34.

Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.

Davies G, Salter J, Hills M, Martin LA, Sacks N, Dowsett M.

Clin Cancer Res. 2003 Jul;9(7):2651-6.

35.

The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update.

Marsden J, Sacks N; UK HRT Trial Management Group.

J Br Menopause Soc. 2002 Dec;8(4):129. No abstract available.

PMID:
12804318
36.

Bone marrow transplantation for myelodysplastic syndrome--who? when? and which?

Luger S, Sacks N.

Bone Marrow Transplant. 2002 Aug;30(4):199-206. Review.

37.

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21.

38.

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.

Davies G, Martin LA, Sacks N, Dowsett M.

Ann Oncol. 2002 May;13(5):669-78. Review.

PMID:
12075734
39.

A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma.

Tan SM, Behranwala KA, Trott PA, Nasiri NA, Moskovic E, Brown G, King DM, Sacks NP, Gui GP.

Eur J Surg Oncol. 2002 Apr;28(3):203-8. Erratum in: Eur J Surg Oncol 2002 Dec;28(8):900. Nasim NA [corrected to Nasiri NA].

PMID:
11944950
40.

Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.

Harper-Wynne CL, Sacks NP, Shenton K, MacNeill FA, Sauven P, Laidlaw IJ, Rayter Z, Miall S, Howes A, Salter J, Hills MJ, Lowe FM, A'Hern R, Nasiri N, Doody D, Iqbal J, Dowsett M.

J Clin Oncol. 2002 Feb 15;20(4):1026-35.

PMID:
11844826
41.

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

Dowsett M, Harper-Wynne C, Boeddinghaus I, Salter J, Hills M, Dixon M, Ebbs S, Gui G, Sacks N, Smith I.

Cancer Res. 2001 Dec 1;61(23):8452-8.

42.

Nipple excised and areola retained after total mastectomy (NEAT).

Gordon AB, Nasiri N, Gui GP, Sacks NP.

J R Soc Med. 2001 Apr;94(4):185-6. No abstract available.

43.

Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women.

Lloyd SM, Watson M, Oaker G, Sacks N, Querci della Rovere U, Gui G.

Psychooncology. 2000 Nov-Dec;9(6):473-85.

PMID:
11180582
44.

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

De Boer RH, Allum WH, Ebbs SR, Gui GP, Johnston SR, Sacks NP, Walsh G, Ashley S, Smith IE.

Ann Oncol. 2000 Sep;11(9):1147-53.

PMID:
11061610
45.

Role of axillary surgery in early breast cancer: review of the current evidence.

Spillane AJ, Sacks NP.

Aust N Z J Surg. 2000 Jul;70(7):515-24.

PMID:
10901581
46.

The natural history of breast cancer--can anything be done about it?

Sacks NP.

Med Leg J. 2000;68 ( Pt 1):16-29. No abstract available.

PMID:
10858672
47.

Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?

Marsden J, Whitehead M, A'Hern R, Baum M, Sacks N.

Fertil Steril. 2000 Feb;73(2):292-9.

PMID:
10685532
48.

Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy.

Assersohn L, Powles TJ, Ashley S, Nash AG, Neal AJ, Sacks N, Chang J, Querci della Rovere U, Naziri N.

Ann Oncol. 1999 Dec;10(12):1451-5.

PMID:
10643535
49.

Which patients with early breast cancer need axillary clearance?

Spillane AJ, Sacks NP.

Swiss Surg. 1999;5(5):205-13. Review.

PMID:
10546518
50.

Treatment and outcome of intracystic papillary carcinoma of the breast.

Harris KP, Faliakou EC, Exon DJ, Nasiri N, Sacks NP, Gui GP.

Br J Surg. 1999 Oct;86(10):1274. No abstract available.

PMID:
10540131

Supplemental Content

Support Center